Article Details

Respiratory Syncytial Virus Therapeutics Market to Hit USD - GlobeNewswire

Retrieved on: 2025-02-13 14:54:08

Tags for this article:

Click the tags to see associated articles and topics

Respiratory Syncytial Virus Therapeutics Market to Hit USD - GlobeNewswire. View article details on hiswai:

Excerpt

Injectable RSV therapeutics, including monoclonal antibodies and vaccines, offer high efficacy and safety, making them the preferred option. The ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up